EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The long-term neuroprotective effects of calcium (Ca2+) modulation in ischemic stroke: a systematic review from animal models

Poppy Kristina Sasmita, Raden Mohamad Javier, Steven Aviano Shenelo, Andra Danika, Andreas Dexter Geson, Bernadus Bernardino Bramantyo

Exploration of Neuroprotective Therapy · 2025

DOI: 10.37349/ent.2025.1004127 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Exploration of Neuroprotective Therapy, 2025. Verfasst von Poppy Kristina Sasmita und 5 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ischemic stroke is a leading cause of disability, with calcium (Ca2+) dysregulation contributing to neuronal injury and impaired recovery. While early clinical trials targeting calcium signaling showed limited success, growing preclinical evidence supports the potential of calcium modulation for long-term neuroprotection. This systematic review evaluates the long-term effects of calcium modulation in animal models of ischemic stroke.

Methods

A comprehensive search across PubMed, Scopus, Web of Science, and the Cochrane Library up to June 2025 identified studies investigating calcium-targeted interventions (e.g., calcium channel blockers, chelators, antioxidants) with ≥ 30 days of follow-up. Risk of bias was assessed using the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I).

Results

Nine studies met the inclusion criteria. Interventions like L-type calcium channel blockers, magnesium sulfate, and ischemic preconditioning consistently reduced infarct volume (e.g., 22.4 ± 0.5% with preconditioning vs. 51.6 ± 2.1% with knockout) and improved neurobehavioral outcomes [e.g., epigallocatechin gallate (EGCG)-treated rats scored 2.17 ± 0.05 vs. 3.63 ± 0.06 in controls]. Molecular pathways involved included phosphoinositide 3-kinase (PI3K)/AKT, stromal interaction molecule 1 (STIM1)/ORAI1, and calcium-sensor proteins such as NCKX2.

Discussion

Calcium modulation holds strong promise for neuroprotection in ischemic stroke models. Although clinical gaps remain, these findings support the development of calcium-targeted therapies for stroke recovery, especially when combined with multimodal strategies.

Zitieren

APA

Sasmita, P. K., Javier, R. M., Shenelo, S. A., Danika, A., Geson, A. D., & Bramantyo, B. B. (2025). The long-term neuroprotective effects of calcium (Ca2+) modulation in ischemic stroke: a systematic review from animal models. Exploration of Neuroprotective Therapy. https://doi.org/10.37349/ent.2025.1004127

Vancouver

Sasmita PK, Javier RM, Shenelo SA, Danika A, Geson AD, Bramantyo BB. The long-term neuroprotective effects of calcium (Ca2+) modulation in ischemic stroke: a systematic review from animal models. Exploration of Neuroprotective Therapy. 2025. doi:10.37349/ent.2025.1004127

BibTeX
@article{Sasmita2025,
  author = {Sasmita, Poppy Kristina and Javier, Raden Mohamad and Shenelo, Steven Aviano and Danika, Andra and Geson, Andreas Dexter and Bramantyo, Bernadus Bernardino},
  title = {The long-term neuroprotective effects of calcium (Ca2+) modulation in ischemic stroke: a systematic review from animal models},
  journal = {Exploration of Neuroprotective Therapy},
  year = {2025},
  doi = {10.37349/ent.2025.1004127}
}
Kostenlos starten →